Mechanisms of action of intravenous immunoglobulin in septic encephalopathy

References

Alexander, J.J., Anderson, A.J., Barnum, S.R., Stevens, B., and Tenner, A.J. (2008). The complement cascade: Yin-Yang in neuroinflammation – neuro-protection and –degeneration. J. Neurochem. 107, 1169–1187.10.1111/j.1471-4159.2008.05668.xSearch in Google Scholar PubMed PubMed Central

Arumugam, T.V., Tang, S.C., Lathia, J.D., Cheng, A., Mughal, M.R., Chigurupati, S., Magnus, T., Chan, S.L., Jo, D.G., Ouyang, X., et al. (2007). Intravenous immunoglobulin (IVIg) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc. Natl. Acad. Sci. USA 104, 14104–14109.10.1073/pnas.0700506104Search in Google Scholar PubMed PubMed Central

Arumugam, T.V., Selvaraj, P.K., Woodruff, T.M., and Mattson, M.P. (2008). Targeting ischemic brain injury with intravenous immunoglobulin. Expert Opin. Ther. Targets 12, 19–29.10.1517/14728222.12.1.19Search in Google Scholar PubMed

Basta, M. (2008). Ambivalent effects of immunoglobulins on the complement system: Activation versus inhibition. Mol. Immunol 45, 4073–4079.10.1016/j.molimm.2008.07.012Search in Google Scholar PubMed

Basta, M., Van Goor, F., Luccioli, S., Billings, E.M., Vortmeyer, A.O., Baranyi, L., Szebeni, J., Alving, C.R., Carroll, M.C., Berkower, I., et al. (2003). F(ab)-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat. Med. 4, 431–438.10.1038/nm836Search in Google Scholar PubMed

Bozza, F.A., Dávila, J.C., Ritter, C., Sonneville, R., Sharshar, T., and Dal-Pizzol, F. (2013). Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock 39, 10–16.10.1097/SHK.0b013e31828fade1Search in Google Scholar PubMed

Chen, Z., Jalabi, W., Shpargel, K.B., Farabaugh, K.T., Dutta, R., Yin, X., Kidd, G.J., Bergmann, C.C., Stohlman, S.A., and Trapp, B.D. (2012). Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J. Neurosci. 32, 11706–11715.10.1523/JNEUROSCI.0730-12.2012Search in Google Scholar PubMed PubMed Central

Craft, J.M., Watterson, D.M., and Van, Eldik, L.J. (2005). Neuroinflammation: a potential therapeutic target. Expert Opin. Ther. Targets 9, 887–900.10.1517/14728222.9.5.887Search in Google Scholar PubMed

Crow, A.R., Song, S., Semple, J.W., Freedman, J., and Lazarus, A.H. (2007). A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood 109, 155–158.10.1182/blood-2006-05-023796Search in Google Scholar PubMed

Dodel, R.C., Du, Y., Depboylu, C., Hampel, H., Frölich, L., Haag, A., Hemmeter, U., Paulsen, S., Teipel, S.J., Brettschneider, S., et al. (2004). Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 75, 1472–1474.10.1136/jnnp.2003.033399Search in Google Scholar PubMed PubMed Central

Esen, F., Senturk, E., Ozcan, P.E., Ahishali, B., Arican, N., Orhan, N., Ekizoglu, O., Kucuk, M., and Kaya, M. (2012). Intravenous immunoglobulins prevent the breakdown of the blood–brain barrier in experimentally induced sepsis. Crit. Care Med. 40, 1214–1220.10.1097/CCM.0b013e31823779caSearch in Google Scholar PubMed

Esen, F., Orhun, G., Ozcan, P.E., Senturk, E., Kucukerden, M., Giris, M., Akcan, U., Yilmaz, C.U., Orhan, N., Arican, N., et al. (2017). Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis. Intensive Care Med. Exp. 5, 1.10.1186/s40635-016-0114-1Search in Google Scholar PubMed PubMed Central

Fang, J., Lian, Y., Xie, K., Cai, S., and Wen, P. (2014). Epigenetic modulation of neuronal apoptosis and cognitive functions in sepsis-associated encephalopathy. Neurol. Sci. 35, 283–288.10.1007/s10072-013-1508-4Search in Google Scholar PubMed

Flierl, M.A., Stahel, P.F., Rittirsch, D., Huber-Lang, M., Niederbichler, A.D., Hoesel, L.M. Touban, B.M., Morgan, S.J., Smith, W.R., Ward, P.A., et al. (2009). Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit. Care 13, R12.10.1186/cc7710Search in Google Scholar PubMed PubMed Central

Gaillard, P.J., de Boer, A.B., and Breimer, D.D. (2003). Pharmacological investigations on LPS-induced permeability changes in the blood-brain barrier in vitro. Microvasc. Res. 65, 24–31.10.1016/S0026-2862(02)00009-2Search in Google Scholar

González, H., Elgueta, D., Montoya, A., and Pacheco, R. (2014). Neuroimmune regulation of microglial activity involved inneuroinflammation and neurodegenerative diseases. J. Neuroimmunol. 274, 1–13.10.1016/j.jneuroim.2014.07.012Search in Google Scholar PubMed

Griffin, W.S., Sheng, J.G., Royston, M.C., Gentleman, S.M., McKenzie, J.E., Graham, D.I., Roberts, G.W., and Mrak, R.E. (1998). Glial-neuronal interactions in Alzheimer’s disease: the potential role of a “cytokine cycle” in disease progression. Brain Pathol. 8, 65–72.10.1111/j.1750-3639.1998.tb00136.xSearch in Google Scholar PubMed PubMed Central

Hernandes, M.S., D’Avila, J.C., Trevelin, S.C., Reis, P.A., Kinjo, E.R., Lopes, L.R., Castro-Faria-Neto, H.C., Cunha, F.Q., Britto, L.R., and Bozza, F.A. (2014). The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J. Neuroinflamm. 11, 36.10.1186/1742-2094-11-36Search in Google Scholar PubMed PubMed Central

Hoogland, I.C., Houbolt, C., van Westerloo, D.J., van Gool, W.A., and van de Beek, D. (2015). Systemic inflammation and microglial activation: systematic review of animal experiments. J. Neuroinflamm. 12, 114.10.1186/s12974-015-0332-6Search in Google Scholar PubMed PubMed Central

Jacob, A., Hensley, L.K., Safratowich, B.D., Quigg, R.J., and Alexander, J.J. (2007). The role of complement cascade in endotoxin-induced septic encephalopathy. Lab. Invest. 87, 1186–1194.10.1038/labinvest.3700686Search in Google Scholar PubMed

Jonas, E., Dwenger, A., and Jonas, M. (1995). Chemiluminescence response and adherence of neutrophils to cultured endothelial cells – influence of immunoglobulin G. J. Biolumin. Chemilumin. 10, 169–173.10.1002/bio.1170100305Search in Google Scholar PubMed

Lapointe, B.M., Herx, L.M., Gill, V., Metz, L.M., and Kubes, P. (2004). IVIg therapy in brain inflammation: etiology dependent differential effects on leukocyte recruitment. Brain 127, 2649–2656.10.1093/brain/awh297Search in Google Scholar PubMed

Lossinsky, A.S. and Shivers, R.R. (2004). Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Histol. Histopathol. 19, 535–564.Search in Google Scholar

Michels, M., Vieira, A.S., Vuolo, F., Zapelini, H.G., Mendonça, B., Mina, F., Dominguini, D., Steckert, A., Schuck, P.F., Quevedo, J., et al. (2015). The role of microglia activation in the development of sepsis-induced long-term cognitive impairment. Brain Behav. Immun. 43, 54–59.10.1016/j.bbi.2014.07.002Search in Google Scholar PubMed

Misra, N., Bayry, J., Ephrem, A., Dasgupta, S., Delignat, S., Duong Van Huyen, J.P., Prost, F., Lacroix-Desmazes, S., Nicoletti, A., Kazatchkine, M.D., et al. (2005). Intravenous immunoglobulin in neurological disorders: a mechanistic perspective. J Neurol. 252, i1–i6.10.1007/s00415-005-1102-7Search in Google Scholar PubMed

Monje, M.L., Toda, H., and Palmer, T.D. (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760–1765.10.1126/science.1088417Search in Google Scholar PubMed

Negi, V.S., Elluru, S., Sibéril, S., Graff-Dubois, S., Mouthon, L., Kazatchkine, M.D., Lacroix-Desmazes, S., Bayry, J., and Kaveri, S.V. (2007). Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J. Clin. Immunol. 27, 233–245.10.1007/s10875-007-9088-9Search in Google Scholar PubMed

Ozcan, P.E., Senturk, E., Orhun, G., Gumru, S., Arican, N., Orhan, N., Yılmaz, C.U., Kaya, M., Aricioglu, F., and Esen, F. (2015). Effects of intravenous immunoglobulin therapy on behavior deficits and functions in sepsis model. Ann. Intensive Care 5, 62.10.1186/s13613-015-0062-zSearch in Google Scholar PubMed PubMed Central

Papadopoulos, M.C., Lamb, F.J., Moss, R.F., Davies, D.C., Tighe, D., and Bennett, E.D. (1999). Faecal peritonitis causes edema and neuronal injury in pig cerebral cortex. Clin. Sci. 96, 461–466.10.1042/cs0960461Search in Google Scholar

Papadopoulos, M.C., Davies, D.C., Moss, R.F., Tighe, D., and Bennett, E.D. (2000). Pathophysiology of septic encephalopathy: a review. Crit. Care Med. 28, 3019–3024.10.1097/00003246-200008000-00057Search in Google Scholar PubMed

Prasad, N.K., Papoff, G., Zeuner, A., Bonnin, E., Kazatchkine, M.D., Ruberti, G., and Kaveri, S.V. (1998). Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J. Immunol. 161, 3781–3790.10.4049/jimmunol.161.7.3781Search in Google Scholar

Pytel, P. and Alexander, J.J. (2009). Pathogenesis of septic encephalopathy. Curr. Opin. Neurol. 22, 283–287.10.1097/WCO.0b013e32832b3101Search in Google Scholar PubMed

Qin, L., Wu, X., Block, M.L., Liu, Y., Breese, G.R., Hong, J.S., Knapp, D.J., and Crews F.T. (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453–462.10.1002/glia.20467Search in Google Scholar PubMed PubMed Central

Riedemann, N.C., Guo, R.F., Neff, T.A., Laudes, I.J., Keller, K.A., Sarma, V.J., Markiewski, M.M., Mastellos, D., Strey, C.W., Pierson, C.L., et al. (2002). Increased C5a receptor expression in sepsis. J. Clin. Invest. 110, 101–108.10.1172/JCI200215409Search in Google Scholar

Sharshar, T., Hopkinson, N.S., Orlikowski, D., and Annane, D. (2005). Science review: the brain in sepsis – culprit and victim. Crit. Care 9, 37–44.10.1186/cc2951Search in Google Scholar PubMed PubMed Central

Stangel, M. and Compston, A. (2001). Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors. J. Neuroimmunol. 112, 63–71.10.1016/S0165-5728(00)00412-4Search in Google Scholar PubMed

Sui, D.M., Xie, Q., Yi, W.J., Gupta, S., Yu, X.Y., Li, J.B., Wang, J., Wang, J.F., and Deng, X.M. (2016). Resveratrol protects against sepsis-associated encephalopathy and inhibits the NLRP3/IL-1β axis in microglia. Mediat. Inflamm. 2016, 1045657.10.1155/2016/1045657Search in Google Scholar PubMed PubMed Central

Toungouz, M., Denys, C.H., De Groote, D., and Dupont, E. (1995). In vitro inhibition of tumor necrosis factor α and interleukin-6 production by intravenous immunoglobulins. Br. J. Haematol. 89, 698–703.10.1111/j.1365-2141.1995.tb08404.xSearch in Google Scholar PubMed

Vaszelka, S., Urbanyi, Z., Pazmany, T., Németh, L., Obála, I., Dung, N.T.K., Ábrahám, C.S., Szabó, G., and Deli, M.A. (2005). Human serum amyloid P component attenuates the bacterial lipopolysaccaride-induced increase in blood brain barrier permeability in mice. Neurosci. Lett. 352, 57–60.10.1016/j.neulet.2003.08.028Search in Google Scholar PubMed

Ward, P.A. (2008). Role of the complement in experimental sepsis. J. Leukoc. Biol. 83, 467–470.10.1189/jlb.0607376Search in Google Scholar PubMed

Weberpals, M., Hermes, M., Hermann, S., Kummer, M.P., Terwel, D., Semmler, A., Berger, M., Schäfers, M., and Heneka, M.T. (2009). NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J. Neurosci. 29, 14177–14184.10.1523/JNEUROSCI.3238-09.2009Search in Google Scholar PubMed PubMed Central